Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial

{ 'indexed': {'date-parts': [[2024, 3, 30]], 'date-time': '2024-03-30T11:06:43Z', 'timestamp': 1711796803762}, 'reference-count': 34, 'publisher': 'Springer Science and Business Media LLC', 'issue': '3', 'license': [ { 'start': { 'date-parts': [[2021, 10, 13]], 'date-time': '2021-10-13T00:00:00Z', 'timestamp': 1634083200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springernature.com/gp/researchers/text-and-data-mining'}, { 'start': { 'date-parts': [[2021, 10, 13]], 'date-time': '2021-10-13T00:00:00Z', 'timestamp': 1634083200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springernature.com/gp/researchers/text-and-data-mining'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2023, 6]]}, 'DOI': '10.1007/s12602-021-09858-5', 'type': 'journal-article', 'created': { 'date-parts': [[2021, 10, 13]], 'date-time': '2021-10-13T18:12:56Z', 'timestamp': 1634148776000}, 'page': '460-468', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 25, 'title': 'Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium ' 'bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum ' 'subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized ' 'Controlled Trial', 'prefix': '10.1007', 'volume': '15', 'author': [ {'given': 'Vladimir', 'family': 'Ivashkin', 'sequence': 'first', 'affiliation': []}, {'given': 'Victor', 'family': 'Fomin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sergey', 'family': 'Moiseev', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michail', 'family': 'Brovko', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7513-1636', 'authenticated-orcid': False, 'given': 'Roman', 'family': 'Maslennikov', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anatoly', 'family': 'Ulyanin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Victoria', 'family': 'Sholomova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria', 'family': 'Vasilyeva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elizaveta', 'family': 'Trush', 'sequence': 'additional', 'affiliation': []}, {'given': 'Oleg', 'family': 'Shifrin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elena', 'family': 'Poluektova', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2021, 10, 13]]}, 'reference': [ { 'key': '9858_CR1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jgm.3303', 'volume': '23', 'author': 'M Mohamadian', 'year': '2021', 'unstructured': 'Mohamadian M, Chiti H, Shoghli A et al (2021) COVID-19: virology, ' 'biology and novel laboratory diagnosis. J Gene Med 23:e3303. ' 'https://doi.org/10.1002/jgm.3303', 'journal-title': 'J Gene Med'}, { 'key': '9858_CR2', 'doi-asserted-by': 'publisher', 'first-page': '753', 'DOI': '10.1136/postgradmedj-2020-138234', 'volume': '96', 'author': 'S Umakanthan', 'year': '2020', 'unstructured': 'Umakanthan S, Sahu P, Ranade AV et al (2020) Origin, transmission, ' 'diagnosis and management of coronavirus disease 2019 (COVID-19). ' 'Postgrad Med 96:753–758. ' 'https://doi.org/10.1136/postgradmedj-2020-138234', 'journal-title': 'Postgrad Med'}, { 'key': '9858_CR3', 'doi-asserted-by': 'publisher', 'first-page': '1291', 'DOI': '10.1007/s12602-019-09628-4', 'volume': '12', 'author': 'EA Trush', 'year': '2020', 'unstructured': 'Trush EA, Poluektova EA, Beniashvilli AG et al (2020) The evolution of ' 'human probiotics: challenges and prospects. Probiotics Antimicrob ' 'Proteins 12:1291–1299. https://doi.org/10.1007/s12602-019-09628-4', 'journal-title': 'Probiotics Antimicrob Proteins'}, { 'key': '9858_CR4', 'doi-asserted-by': 'publisher', 'first-page': '32', 'DOI': '10.4081/itjm.2018.931', 'volume': '12', 'author': 'O Zolnikova', 'year': '2018', 'unstructured': 'Zolnikova O, Komkova I, Potskherashvili N et al (2018) Application of ' 'probiotics for acute respiratory tract infections. Ital J Med 12:32–38. ' 'https://doi.org/10.4081/itjm.2018.931', 'journal-title': 'Ital J Med'}, { 'key': '9858_CR5', 'doi-asserted-by': 'publisher', 'first-page': '1632', 'DOI': '10.1016/j.mayocp.2020.06.003', 'volume': '95', 'author': 'R Tariq', 'year': '2020', 'unstructured': 'Tariq R, Saha S, Furqan F et al (2020) Prevalence and mortality of ' 'COVID-19 patients with gastrointestinal symptoms: a systematic review ' 'and meta-analysis. Mayo Clin Proc 95:1632–1648', 'journal-title': 'Mayo Clin Proc'}, { 'key': '9858_CR6', 'doi-asserted-by': 'publisher', 'first-page': '348', 'DOI': '10.1080/23744235.2021.1885733', 'volume': '53', 'author': 'R Maslennikov', 'year': '2021', 'unstructured': 'Maslennikov R, Poluektova E, Ivashkin V et al (2021) Diarrhoea in adults ' 'with coronavirus disease-beyond incidence and mortality: a systematic ' 'review and meta-analysis. Infect Dis (Lond) 53:348–360. ' 'https://doi.org/10.1080/23744235.2021.1885733', 'journal-title': 'Infect Dis (Lond)'}, { 'key': '9858_CR7', 'doi-asserted-by': 'publisher', 'unstructured': 'Maslennikov R, Ivashkin V, Ufimtseva A, Poluektova E (2021) A clinical ' 'variant of coronavirus disease 2019 with diarrhoea as the initial ' 'symptom compared with other variants. Minerva Gastroenterol (Torino). ' 'https://doi.org/10.23736/S2724-5985.21.02827-0', 'DOI': '10.23736/S2724-5985.21.02827-0'}, { 'key': '9858_CR8', 'doi-asserted-by': 'publisher', 'first-page': '3208', 'DOI': '10.3748/wjg.v27.i23.3208', 'volume': '27', 'author': 'K Megyeri', 'year': '2021', 'unstructured': 'Megyeri K, Dernovics Á, Al-Luhaibi ZII, Rosztóczy A (2021) ' 'COVID-19-associated diarrhea. World J Gastroenterol 27:3208–3222. ' 'https://doi.org/10.3748/wjg.v27.i23.3208', 'journal-title': 'World J Gastroenterol'}, { 'key': '9858_CR9', 'doi-asserted-by': 'publisher', 'first-page': '103', 'DOI': '10.1186/s12876-018-0831-x', 'volume': '18', 'author': 'V Agamennone', 'year': '2018', 'unstructured': 'Agamennone V, Krul CAM, Rijkers G et al (2018) A practical guide for ' 'probiotics applied to the case of antibiotic-associated diarrhoea in the ' 'Netherlands. BMC Gastroenterol 18:103. ' 'https://doi.org/10.1186/s12876-018-0831-x', 'journal-title': 'BMC Gastroenterol'}, { 'key': '9858_CR10', 'doi-asserted-by': 'publisher', 'first-page': '1-19', 'DOI': '10.1177/1756284819878950', 'volume': '12', 'author': 'DJ Cangemi', 'year': '2019', 'unstructured': 'Cangemi DJ, Lacy BE (2019) Management of irritable bowel syndrome with ' 'diarrhoea: a review of nonpharmacological and pharmacological ' 'interventions. Ther Adv Gastroenterol 12:1-19. ' 'https://doi.org/10.1177/1756284819878950', 'journal-title': 'Ther Adv Gastroenterol'}, { 'key': '9858_CR11', 'doi-asserted-by': 'publisher', 'first-page': '436', 'DOI': '10.1136/gut.52.3.436', 'volume': '52', 'author': 'E Isolauri', 'year': '2003', 'unstructured': 'Isolauri E (2003) Probiotics for infectious diarrhoea Gut 52:436–437. ' 'https://doi.org/10.1136/gut.52.3.436', 'journal-title': 'Probiotics for infectious diarrhoea Gut'}, { 'key': '9858_CR12', 'doi-asserted-by': 'publisher', 'first-page': '990', 'DOI': '10.1097/MEG.0000000000001817', 'volume': '33', 'author': 'K Wijarnpreecha', 'year': '2021', 'unstructured': 'Wijarnpreecha K, Ungprasert P, Panjawatanan P et al (2021) COVID-19 and ' 'liver injury: a meta-analysis. Eur J Gastroenterol Hepatol 33:990–995. ' 'https://doi.org/10.1097/MEG.0000000000001817', 'journal-title': 'Eur J Gastroenterol Hepatol'}, { 'key': '9858_CR13', 'doi-asserted-by': 'publisher', 'unstructured': 'Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Shirokova E (2021) ' 'Probiotics in hepatology: an update. World J Hepatol 13:1154–1166 ' 'https://doi.org/10.4254/wjh.v13.i9.1154', 'DOI': '10.4254/wjh.v13.i9.1154'}, { 'key': '9858_CR14', 'doi-asserted-by': 'publisher', 'first-page': '1819', 'DOI': '10.1007/s00705-021-05036-8', 'volume': '166', 'author': 'R Mirzaei', 'year': '2021', 'unstructured': 'Mirzaei R, Attar A, Papizadeh S et al (2021) The emerging role of ' 'probiotics as a mitigation strategy against coronavirus disease 2019 ' '(COVID-19). Arch Virol 166:1819–1840. ' 'https://doi.org/10.1007/s00705-021-05036-8', 'journal-title': 'Arch Virol'}, { 'key': '9858_CR15', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1016/j.nutres.2020.12.014', 'volume': '87', 'author': 'K Singh', 'year': '2021', 'unstructured': 'Singh K, Rao A (2021) Probiotics: a potential immunomodulator in ' 'COVID-19 infection management. Nutr Res 87:1–12. ' 'https://doi.org/10.1016/j.nutres.2020.12.014', 'journal-title': 'Nutr Res'}, { 'key': '9858_CR16', 'doi-asserted-by': 'publisher', 'first-page': '1138', 'DOI': '10.1007/s12602-021-09748-w', 'volume': '13', 'author': 'S Patra', 'year': '2021', 'unstructured': 'Patra S, Saxena S, Sahu N et al (2021) Systematic network and ' 'meta-analysis on the antiviral mechanisms of probiotics: a preventive ' 'and treatment strategy to mitigate SARS-CoV-2 infection. Probiotics ' 'Antimicrob Proteins 13:1138–1156. ' 'https://doi.org/10.1007/s12602-021-09748-w', 'journal-title': 'Probiotics Antimicrob Proteins'}, { 'key': '9858_CR17', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1080/19490976.2021.1900997', 'volume': '13', 'author': 'BH Mullish', 'year': '2021', 'unstructured': 'Mullish BH, Marchesi JR, McDonald JAK et al (2021) Probiotics reduce ' 'self-reported symptoms of upper respiratory tract infection in ' 'overweight and obese adults: should we be considering probiotics during ' 'viral pandemics? Gut Microbes 13:1–9. ' 'https://doi.org/10.1080/19490976.2021.1900997', 'journal-title': 'Gut Microbes'}, { 'key': '9858_CR18', 'doi-asserted-by': 'publisher', 'first-page': '611', 'DOI': '10.1007/s12602-020-09727-7', 'volume': '13', 'author': 'S Manna', 'year': '2021', 'unstructured': 'Manna S, Chowdhury T, Chakraborty R, Mandal SM (2021) Probiotics-derived ' 'peptides and their immunomodulatory molecules can play a preventive role ' 'against viral diseases including COVID-19. Probiotics Antimicrob ' 'Proteins 13:611–623. https://doi.org/10.1007/s12602-020-09727-7', 'journal-title': 'Probiotics Antimicrob Proteins'}, { 'key': '9858_CR19', 'doi-asserted-by': 'publisher', 'first-page': '17', 'DOI': '10.1038/s41538-020-00078-9', 'volume': '4', 'author': 'AN Olaimat', 'year': '2020', 'unstructured': 'Olaimat AN, Aolymat I, Al-Holy M et al (2020) The potential application ' 'of probiotics and prebiotics for the prevention and treatment of ' 'COVID-19. NPJ Sci Food 4:17. https://doi.org/10.1038/s41538-020-00078-9', 'journal-title': 'NPJ Sci Food'}, { 'key': '9858_CR20', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.micpath.2020.104452', 'volume': '148', 'author': 'M Mahooti', 'year': '2020', 'unstructured': 'Mahooti M, Miri SM, Abdolalipour E, Ghaemi A (2020) The immunomodulatory ' 'effects of probiotics on respiratory viral infections: a hint for ' 'COVID-19 treatment? Microb Pathog 148:104452. ' 'https://doi.org/10.1016/j.micpath.2020.104452', 'journal-title': 'Microb Pathog'}, { 'key': '9858_CR21', 'doi-asserted-by': 'publisher', 'first-page': '205873842096130', 'DOI': '10.1177/2058738420961304', 'volume': '34', 'author': 'HS Bozkurt', 'year': '2020', 'unstructured': 'Bozkurt HS, Quigley EM (2020) The probiotic Bifidobacterium in the ' 'management of Coronavirus: a theoretical basis. Int J Immunopathol ' 'Pharmacol 34:2058738420961304. https://doi.org/10.1177/2058738420961304', 'journal-title': 'Int J Immunopathol Pharmacol'}, { 'key': '9858_CR22', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.intimp.2021', 'volume': '95', 'author': 'Q Li', 'year': '2021', 'unstructured': 'Li Q, Cheng F, Xu Q et al (2021) The role of probiotics in coronavirus ' 'disease-19 infection in Wuhan: a retrospective study of 311 severe ' 'patients. Int Immunopharmacol 95:107531. ' 'https://doi.org/10.1016/j.intimp.2021', 'journal-title': 'Int Immunopharmacol'}, { 'key': '9858_CR23', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fnut.2020.613928', 'volume': '7', 'author': 'G Ceccarelli', 'year': '2021', 'unstructured': 'Ceccarelli G, Borrazzo C, Pinacchio C et al (2021) Oral bacteriotherapy ' 'in patients with COVID-19: a retrospective cohort study. Front Nutr ' '7:613928. https://doi.org/10.3389/fnut.2020.613928', 'journal-title': 'Front Nutr'}, { 'key': '9858_CR24', 'doi-asserted-by': 'publisher', 'first-page': '389', 'DOI': '10.3389/fmed.2020.00389', 'volume': '7', 'author': 'G d’Ettorre', 'year': '2020', 'unstructured': 'd’Ettorre G, Ceccarelli G, Marazzato M et al (2020) Challenges in the ' 'management of SARS-CoV2 infection: the role of oral bacteriotherapy as ' 'complementary therapeutic strategy to avoid the progression of COVID-19. ' 'Front Med (Lausanne) 7:389. https://doi.org/10.3389/fmed.2020.00389', 'journal-title': 'Front Med (Lausanne)'}, { 'key': '9858_CR25', 'doi-asserted-by': 'publisher', 'first-page': '531', 'DOI': '10.1007/s00392-020-01626-9', 'volume': '109', 'author': 'B Li', 'year': '2020', 'unstructured': 'Li B, Yang J, Zhao F et al (2020) Prevalence and impact of ' 'cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol ' '109:531–538. https://doi.org/10.1007/s00392-020-01626-9', 'journal-title': 'Clin Res Cardiol'}, { 'key': '9858_CR26', 'unstructured': 'Kamkin E et al. (2020) Interim guidelines for the prevention, diagnosis ' 'and treatment of new coronaviral infection (COVID-19). ' 'https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/051/777/original/030902020_COVID-19_v8.pdf. ' 'Accessed 03 Sept\xa02020'}, { 'key': '9858_CR27', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.4081/itjm.2020.1185', 'volume': '14', 'author': 'V Ivashkin', 'year': '2020', 'unstructured': 'Ivashkin V, Fadeeva M, Skhirtladze M et al (2020) Intestinal microbiota ' 'in the pathogenesis of chronic heart failure. Ital J Med 14:1–8. ' 'https://doi.org/10.4081/itjm.2020.1185', 'journal-title': 'Ital J Med'}, { 'key': '9858_CR28', 'doi-asserted-by': 'publisher', 'first-page': '1149', 'DOI': '10.1111/apt.13404', 'volume': '42', 'author': 'H Szajewska', 'year': '2015', 'unstructured': 'Szajewska H, Kołodziej M (2015) Systematic review with meta-analysis: ' 'Lactobacillus rhamnosus GG in the prevention of antibiotic-associated ' 'diarrhoea in children and adults. Aliment Pharmacol Ther 42:1149–1157. ' 'https://doi.org/10.1111/apt.13404', 'journal-title': 'Aliment Pharmacol Ther'}, { 'key': '9858_CR29', 'doi-asserted-by': 'publisher', 'first-page': '4999', 'DOI': '10.3748/wjg.v25.i33.4999', 'volume': '25', 'author': 'YT Li', 'year': '2019', 'unstructured': 'Li YT, Xu H, Ye JZ (2019) Efficacy of Lactobacillus rhamnosus GG in ' 'treatment of acute pediatric diarrhea: a systematic review with ' 'meta-analysis. World J Gastroenterol 25:4999–5016. ' 'https://doi.org/10.3748/wjg.v25.i33.4999', 'journal-title': 'World J Gastroenterol'}, { 'key': '9858_CR30', 'doi-asserted-by': 'publisher', 'unstructured': 'Di JB, Gai ZT (2020) Protective efficacy of probiotics on the treatment ' 'of acute rotavirus diarrhea in children: an updated meta-analysis. Eur ' 'Rev Med Pharmacol Sci 24:9675–9683. ' 'https://doi.org/10.26355/eurrev_202009_23057', 'DOI': '10.26355/eurrev_202009_23057'}, { 'key': '9858_CR31', 'doi-asserted-by': 'publisher', 'first-page': '1024', 'DOI': '10.3389/fbioe.2020.01024', 'volume': '8', 'author': 'P Rasinkangas', 'year': '2020', 'unstructured': 'Rasinkangas P, Tytgat HLP, Ritari J et al (2020) Characterization of ' 'highly mucus-adherent non-GMO derivatives of Lacticaseibacillus ' 'rhamnosus GG. Front Bioeng Biotechnol 8:1024. ' 'https://doi.org/10.3389/fbioe.2020.01024', 'journal-title': 'Front Bioeng Biotechnol'}, { 'key': '9858_CR32', 'doi-asserted-by': 'publisher', 'first-page': '738', 'DOI': '10.3389/fmicb.2016.00738', 'volume': '7', 'author': 'L Valdés-Varela', 'year': '2016', 'unstructured': 'Valdés-Varela L, Hernández-Barranco AM, Ruas-Madiedo P, Gueimonde M ' '(2016) Effect of Bifidobacterium upon Clostridium difficile growth and ' 'toxicity when co-cultured in different prebiotic substrates. Front ' 'Microbiol 7:738. https://doi.org/10.3389/fmicb.2016.00738', 'journal-title': 'Front Microbiol'}, { 'key': '9858_CR33', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0173979', 'volume': '12', 'author': 'T Kawahara', 'year': '2017', 'unstructured': 'Kawahara T, Makizaki Y, Oikawa Y et al (2017) Oral administration of ' 'Bifidobacterium bifidum G9–1 alleviates rotavirus gastroenteritis ' 'through regulation of intestinal homeostasis by inducing mucosal ' 'protective factors. PLoS One 12:e0173979. ' 'https://doi.org/10.1371/journal.pone.0173979', 'journal-title': 'PLoS ONE'}, { 'key': '9858_CR34', 'doi-asserted-by': 'publisher', 'first-page': 'C1084', 'DOI': '10.1152/ajpcell.00194.2014', 'volume': '307', 'author': 'A Kumar', 'year': '2014', 'unstructured': 'Kumar A, Hecht C, Priyamvada S (2014) Probiotic Bifidobacterium species ' 'stimulate human SLC26A3 gene function and expression in intestinal ' 'epithelial cells. Am J Physiol Cell Physiol 307:C1084–C1092. ' 'https://doi.org/10.1152/ajpcell.00194.2014', 'journal-title': 'Am J Physiol Cell Physiol'}], 'container-title': 'Probiotics and Antimicrobial Proteins', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s12602-021-09858-5.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s12602-021-09858-5/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s12602-021-09858-5.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 5, 26]], 'date-time': '2023-05-26T09:55:06Z', 'timestamp': 1685094906000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s12602-021-09858-5'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 10, 13]]}, 'references-count': 34, 'journal-issue': {'issue': '3', 'published-print': {'date-parts': [[2023, 6]]}}, 'alternative-id': ['9858'], 'URL': 'http://dx.doi.org/10.1007/s12602-021-09858-5', 'relation': {}, 'ISSN': ['1867-1306', '1867-1314'], 'subject': ['Molecular Biology', 'Molecular Medicine', 'Microbiology'], 'container-title-short': 'Probiotics & Antimicro. Prot.', 'published': {'date-parts': [[2021, 10, 13]]}, 'assertion': [ { 'value': '5 October 2021', 'order': 1, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '13 October 2021', 'order': 2, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'The study was approved by the local ethics committee (Conclusion №. 34-20 of ' 'September 9, 2020) in accordance with the Declaration of Helsinki.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Ethics Approval'}}, { 'value': 'Informed consent was obtained from all individual participants included in the ' 'study.', 'order': 3, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Consent to Participate'}}, { 'value': 'Patients’ personal data are not published.', 'order': 4, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Consent for Publication'}}, { 'value': 'The authors declare no competing interests.', 'order': 5, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflicts of Interest'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}